The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters
The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives
Backed by Semaglutide launches, the company reported 47% quarter-on-quarter revenue growth in Q4 FY26, with EBITDA expanding more than fivefold
The company witnesses strong growth across its India, Africa, and emerging markets businesses, while securing regulatory approval for the first AB-rated gVentolin in the U.S. market
We are building an AI-native operating system for pharma sales and distribution
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
Shashwat Goenka takes over as Vice President of industry body
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
The company highlighted a series of strategic moves during the year, including the acquisition of WOKADINE, marking its entry into the Rs. 648 Cr Povidone Iodine market
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Subscribe To Our Newsletter & Stay Updated
